Welcome to RTTNews premium services. Information is the key to success in trading and investing. For over 15 years, RTTNews has been providing all the news and analysis from around the globe that can impact individual stocks and broader financial markets to some of the leading banks, brokerages and hedge funds. Now RTT is making this same information available to individual investors and traders.
Signup Now
7-Day Free Trial (no credit card required)
Biotech investment is one of the exciting spaces in the stock market. The companies in this sector focus on clinical research and development of new drugs.
There is tremendous potential for stocks to deliver outstanding gains when companies report positive trial data or when their drugs obtain FDA approval.
At RTTNews, a dedicated team tracks these companies and developments. As a subscriber, you will have access to all the timely news, time-sensitive information, and alerts that can enable you to make sound investment decisions.
Sign-up today for your FREE 7-day trial, and continue using the service for $199/month
The existing premium services 'Short-Term Investor’, 'Under The Radar - Small Stocks – Big Potential', and 'Emerging Biostocks - Investing in Biotech and Pharma' now under a single umbrella...‘RTT Intelligent Investor’.
Absolutely free for a week! A brand new Macro Intelligence’ premium column packs more punch into the new service. Signing up also gives complimentary access to value-addons including research articles, Trending market/stock movers, Top stories of the day, news that impact stocks and markets, key upcoming Wall Street and other events, and much more.
Sign-up today for your FREE 7-day trial, and continue using the service for $99/month
Signup Now
7-Day Free Trial (no credit card required)